Andrew V. Biankin

发表

Corrigendum: Signatures of mutational processes in human cancer

Roland Eils, Natalie Jäger, Adam P. Butler, 2013, Nature.

PINA v2.0: mining interactome modules

Jianmin Wu, Sampsa Hautaniemi, Sean M. Grimmond, 2011, Nucleic Acids Res..

βIII-Tubulin: A novel mediator of chemoresistance and metastases in pancreatic cancer

David Goldstein, Maria Kavallaris, Andrew V. Biankin, 2014, Oncotarget.

Patient-centric trials for therapeutic development in precision oncology

Steven Piantadosi, Andrew V. Biankin, A. Biankin, 2015, Nature.

The Challenges of Precision Oncology Drug Development and Implementation

Andrew V. Biankin, A. Biankin, S. Hollingsworth, 2015, Public Health Genomics.

Interrogating open issues in cancer precision medicine with patient-derived xenografts

Hans Clevers, Manuel Hidalgo, Eva Budinská, 2017, Nature Reviews Cancer.

Histone deacetylase 2 and N-Myc reduce p53 protein phosphorylation at serine 46 by repressing gene transcription of tumor protein 53-induced nuclear protein 1

Tao Liu, Wendy B. London, Andrew V. Biankin, 2014, Oncotarget.

qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles

Jianmin Wu, Matthew Anderson, Sean M. Grimmond, 2012, PloS one.

Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling

Jianmin Wu, Sean M. Grimmond, Christian Pilarsky, 2014, Cell.

Somatic Point Mutation Calling in Low Cellularity Tumors

Jianmin Wu, Matthew Anderson, Peter J. Wilson, 2013, PloS one.